<?xml version="1.0" encoding="UTF-8"?>
<p id="p0230">In summary, it can be concluded that these nucleic acid-based therapeutic agents have proved to be a potent and versatile group of antiviral drugs that have already shown potential efficacy against several viruses including SARS-CoV and other chronic diseases. In-vitro and in-vivo studies have proclaimed their importance as promising antiviral agents. These nucleic-acid based inhibitors, when fully developed as drug molecules it may use against SARS-CoV-2 which can be an effective line of treatment for various other viral diseases.</p>
